Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

delta-8-tetrahydrocannabinol

An analogue of tetrahydrocannabinol (THC), with potential antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective activities. Delta-8-tetrahydrocannabinol (delta-8-THC) binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system; CB1 receptor activation may inhibit adenyl cyclase, increase mitogen-activated protein kinase activities, modulate several potassium channel conductances and inhibit N- and P/Q-type Ca2+ channels. This agent exhibits a lower psychotropic potency than delta-9-tetrahydrocannabinol (delta-9-THC), the primary form of THC found in cannabis.
Abbreviation:delta-8-THC
Search NCI's Drug Dictionary